Persistent Asset Partners Ltd Sells 6,065 Shares of Tenet Healthcare Corporation $THC

Persistent Asset Partners Ltd reduced its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 48.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,456 shares of the company’s stock after selling 6,065 shares during the quarter. Persistent Asset Partners Ltd’s holdings in Tenet Healthcare were worth $1,311,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. William B. Walkup & Associates Inc. acquired a new stake in shares of Tenet Healthcare in the third quarter valued at about $32,000. Westside Investment Management Inc. lifted its stake in Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after acquiring an additional 96 shares during the last quarter. Trust Co. of Vermont acquired a new position in shares of Tenet Healthcare during the 3rd quarter worth about $41,000. Canada Pension Plan Investment Board bought a new position in Tenet Healthcare during the second quarter worth about $35,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Tenet Healthcare by 2,227.3% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 256 shares of the company’s stock worth $45,000 after acquiring an additional 245 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $227.68 on Friday. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $235.77. The firm has a market capitalization of $19.80 billion, a P/E ratio of 14.70, a P/E/G ratio of 1.14 and a beta of 1.44. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The company’s 50 day moving average price is $201.26 and its two-hundred day moving average price is $196.69.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently commented on THC shares. Barclays upped their price target on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a research note on Friday, February 13th. KeyCorp upped their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Thursday, February 12th. Cantor Fitzgerald increased their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. JPMorgan Chase & Co. raised their price objective on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $265.00 price target on shares of Tenet Healthcare in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $246.71.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.